File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Clinico-pathological Associations with Serum Thrombomodulin Level in Patients with Lupus Nephritis

TitleClinico-pathological Associations with Serum Thrombomodulin Level in Patients with Lupus Nephritis
Authors
Issue Date2020
PublisherAmerican Society of Nephrology. The Journal's web site is located at http://www.jasn.org
Citation
American Society of Nephrology (ASN) Kidney Week 2020: Reimagined, Digital Meeting, 22-25 October 2020. In Journal of the American Society of Nephrology, 2020, v. 31 n. Suppl., p. 553, abstract no. PO1769 How to Cite?
AbstractBACKGROUND: Conventional serological markers do not always correlate with clinical activity or histolopathology in lupus nephritis (LN). There is evidence of endothelial activation and injury in LN pathogenesis. Thrombomodulin (TM), a component of endothelial glycocalyx, is shed into the circulation in endothelial cell injury. We investigated clinico-pathological associations of circulating TM level. METHODS: TM level was measured by ELISA in sera collected serially every 3-4 months over >2 years (n=482) from 31 patients with biopsy-proven Class III/IV LN. Patients with non-renal SLE or non-lupus kidney diseases (CKD) and healthy subjects were included as Controls. RESULTS: Patients with active LN had the highest serum TM level, compared with LN patients in remission, patients with active non-renal SLE, CKD patients, or healthy subjects (P<0.01, for all). Serum TM level correlated with anti-dsDNA antibody titre, proteinuria, serum creatinine, SLEDAI-2K and renal SLEDAI-2K score; and inversely correlated with eGFR and C3 (P<0.05, for all). 8 patients had blood samples collected before disease flare, and 6 showed increased TM level (3.65±2.16 months before clinical flare). All episodes of LN flare were accompanied by elevated TM level, which decreased after treatment. A temporal relationship was noted between TM level and anti-dsDNA titre and C3 levels, proteinuria, SLEDAI-2K and renal SLEDAI-2K scores. TM level also correlated with renal interstitial inflammation score (r=0.54, P=0.0081). ROC analysis showed that serum TM level distinguished active LN from healthy subjects (sensitivity 100.00%, specificity 100.00%), from LN in remission (sensitivity 89.66%, specificity 68.97%), from active non-renal SLE (sensitivity 90.91%, specificity 100.00%), and from CKD (sensitivity 89.66%, specificity 56.52%) (P<0.001, for all). CONCLUSION: Determination of serum TM level may facilitate early diagnosis of active LN, and may be useful in monitoring the response to treatment.
DescriptionSession: Glomerular Diseases: Lupus and Membranous - 1202 Glomerular Diseases: Immunology and Inflammation - Abstract no. PO1769
Persistent Identifierhttp://hdl.handle.net/10722/300968
ISSN
2023 Impact Factor: 10.3
2023 SCImago Journal Rankings: 3.409

 

DC FieldValueLanguage
dc.contributor.authorChan, DTM-
dc.contributor.authorYu, KYC-
dc.contributor.authorYap, YHD-
dc.contributor.authorYung, SSY-
dc.date.accessioned2021-07-06T03:12:44Z-
dc.date.available2021-07-06T03:12:44Z-
dc.date.issued2020-
dc.identifier.citationAmerican Society of Nephrology (ASN) Kidney Week 2020: Reimagined, Digital Meeting, 22-25 October 2020. In Journal of the American Society of Nephrology, 2020, v. 31 n. Suppl., p. 553, abstract no. PO1769-
dc.identifier.issn1046-6673-
dc.identifier.urihttp://hdl.handle.net/10722/300968-
dc.descriptionSession: Glomerular Diseases: Lupus and Membranous - 1202 Glomerular Diseases: Immunology and Inflammation - Abstract no. PO1769-
dc.description.abstractBACKGROUND: Conventional serological markers do not always correlate with clinical activity or histolopathology in lupus nephritis (LN). There is evidence of endothelial activation and injury in LN pathogenesis. Thrombomodulin (TM), a component of endothelial glycocalyx, is shed into the circulation in endothelial cell injury. We investigated clinico-pathological associations of circulating TM level. METHODS: TM level was measured by ELISA in sera collected serially every 3-4 months over >2 years (n=482) from 31 patients with biopsy-proven Class III/IV LN. Patients with non-renal SLE or non-lupus kidney diseases (CKD) and healthy subjects were included as Controls. RESULTS: Patients with active LN had the highest serum TM level, compared with LN patients in remission, patients with active non-renal SLE, CKD patients, or healthy subjects (P<0.01, for all). Serum TM level correlated with anti-dsDNA antibody titre, proteinuria, serum creatinine, SLEDAI-2K and renal SLEDAI-2K score; and inversely correlated with eGFR and C3 (P<0.05, for all). 8 patients had blood samples collected before disease flare, and 6 showed increased TM level (3.65±2.16 months before clinical flare). All episodes of LN flare were accompanied by elevated TM level, which decreased after treatment. A temporal relationship was noted between TM level and anti-dsDNA titre and C3 levels, proteinuria, SLEDAI-2K and renal SLEDAI-2K scores. TM level also correlated with renal interstitial inflammation score (r=0.54, P=0.0081). ROC analysis showed that serum TM level distinguished active LN from healthy subjects (sensitivity 100.00%, specificity 100.00%), from LN in remission (sensitivity 89.66%, specificity 68.97%), from active non-renal SLE (sensitivity 90.91%, specificity 100.00%), and from CKD (sensitivity 89.66%, specificity 56.52%) (P<0.001, for all). CONCLUSION: Determination of serum TM level may facilitate early diagnosis of active LN, and may be useful in monitoring the response to treatment.-
dc.languageeng-
dc.publisherAmerican Society of Nephrology. The Journal's web site is located at http://www.jasn.org-
dc.relation.ispartofJournal of the American Society of Nephrology-
dc.relation.ispartofAmerican Society of Nephrology (ASN) Kidney Week 2020-
dc.titleClinico-pathological Associations with Serum Thrombomodulin Level in Patients with Lupus Nephritis-
dc.typeConference_Paper-
dc.identifier.emailChan, DTM: dtmchan@hku.hk-
dc.identifier.emailYap, YHD: desmondy@hku.hk-
dc.identifier.emailYung, SSY: ssyyung@hku.hk-
dc.identifier.authorityChan, DTM=rp00394-
dc.identifier.authorityYap, YHD=rp01607-
dc.identifier.authorityYung, SSY=rp00455-
dc.description.natureabstract-
dc.identifier.hkuros323300-
dc.identifier.volume31-
dc.identifier.issueSuppl.-
dc.identifier.spage553, abstract no. PO1769-
dc.identifier.epage553, abstract no. PO1769-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats